Sylvia
Flight #5342: I Will Remember You
- Messages
- 84,278
International Testing Agency's news release (Feb. 22, 2022) - The ITA asserts an apparent anti-doping rule violation against Spanish athlete Laura Barquero:
The AAF1 returned for the non-specified prohibited substance Clostebol metabolite 4-chloro-3α-hydroxy-androst-4-en-17-one according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee (IOC) during an in-competition anti-doping control on 18 February 2022 during the Pair Skating (short program). The result was reported by the WADA-accredited laboratory in Beijing on 21 February 2022.
The athlete has been informed of the case. She has the right to request the analysis of the B-sample.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the IOC Anti-Doping Rules applicable to the Olympic Games Beijing 2022 (IOC ADR).
Given that the case is underway, there will be no further comments during the ongoing proceeding.

The AAF1 returned for the non-specified prohibited substance Clostebol metabolite 4-chloro-3α-hydroxy-androst-4-en-17-one according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee (IOC) during an in-competition anti-doping control on 18 February 2022 during the Pair Skating (short program). The result was reported by the WADA-accredited laboratory in Beijing on 21 February 2022.
The athlete has been informed of the case. She has the right to request the analysis of the B-sample.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the IOC Anti-Doping Rules applicable to the Olympic Games Beijing 2022 (IOC ADR).
Given that the case is underway, there will be no further comments during the ongoing proceeding.

Last edited: